Daily feed · SEC Form 4 filings
Significant insider purchases — Jul 24, 2018
Open-market purchases of at least $50,000 — or at least $500,000 when the buyer is a 10% owner.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2018 PForm 4 → | Jul 23, 9:13 pm EDT | GOLDRICH MINING COGRMC | William OrchowDirector | 853,868 | $35.00 | $29,885,380 | 2,002,428 | +74.3% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 24, 9:45 am EDT | INTERNATIONAL FLAVORS & FRAGRANCES INCIFF | Winder Investment Pte Ltd10% Owner | 104,808 | $127.58 | $13,371,216 | 14,600,000 | +0.72% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 5:01 pm EDT | Allakos Inc.ALLK | Alta Partners VIII, L.P. +710% Owner | 250,000 | $18.00 | $4,500,000 | 11,519,200 | +2.22% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 5:03 pm EDT | Allakos Inc.ALLK | Daniel JanneyDirector, 10% Owner | 250,000 | $18.00 | $4,500,000 | 11,519,200 | +2.22% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 8:12 pm EDT | CONSTELLATION PHARMACEUTICALS INCCNST | Casdin Capital, LLC +510% Owner | 266,667 | $15.00 | $4,000,005 | 612,450 | +77.1% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 8:04 pm EDT | CONSTELLATION PHARMACEUTICALS INCCNST | Anthony B EvninDirector, 10% Owner | 133,334 | $15.00 | $2,000,010 | 2,519,236 | +5.59% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 5:07 pm EDT | Allakos Inc.ALLK | RiverVest Venture Fund III, L.P. +510% Owner | 111,111 | $18.00 | $1,999,998 | 7,371,252 | +1.53% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 5:08 pm EDT | Allakos Inc.ALLK | John P McKearnDirector, 10% Owner | 111,111 | $18.00 | $1,999,998 | 7,371,252 | +1.53% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 8:15 pm EDT | CONSTELLATION PHARMACEUTICALS INCCNST | REGENTS OF THE UNIVERSITY OF CALIFORNIA10% Owner | 133,333 | $15.00 | $1,999,995 | 2,297,406 | +6.16% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 4:54 pm EDT | CONSTELLATION PHARMACEUTICALS INCCNST | Alexandria Venture Investments, LLC10% Owner | 66,667 | $15.00 | $1,000,005 | 216,304 | +44.6% | plan? |
| Jul 20, 2018 PForm 4 → | Jul 23, 4:33 pm EDT | Rubius Therapeutics, Inc.RUBY | Jonathan SymondsDirector | 25,000 | $23.00 | $575,000 | 25,000 | — | plan? |
| Jul 19, 2018 PForm 4 → | Jul 23, 7:30 pm EDT | DISH Network CORPDISH | James DefrancoExecutive Vice President, Director | 15,000 | $30.99 | $464,900 | 1,183,529 | +1.28% | plan? |
| Nov 21, 2017 PForm 4 → | Jul 23, 2018, 4:15 pm EDT | Sterling Bancorp, Inc.SBT | Peter C. SinatraDirector | 29,415 | $12.00 | $352,980 | 29,415 | — | plan? late |
| Jul 20, 2018 PForm 4 → | Jul 23, 4:33 pm EDT | Rubius Therapeutics, Inc.RUBY | Francis M CussDirector | 10,000 | $23.00 | $230,000 | 10,000 | — | plan? |
| Jul 20, 2018 PForm 4 → | Jul 23, 4:34 pm EDT | Rubius Therapeutics, Inc.RUBY | Catherine A. SohnDirector | 2,500 | $23.00 | $57,500 | 2,500 | — | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.